Cargando…
The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
BACKGROUND: Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854075/ https://www.ncbi.nlm.nih.gov/pubmed/36670466 http://dx.doi.org/10.1186/s40001-023-01011-y |
_version_ | 1784873038268858368 |
---|---|
author | Salari, Nader Ghasemi, Hooman Fatahian, Reza Mansouri, Kamran Dokaneheifard, Sadat Shiri, Mohammad hossain Hemmati, Mahvan Mohammadi, Masoud |
author_facet | Salari, Nader Ghasemi, Hooman Fatahian, Reza Mansouri, Kamran Dokaneheifard, Sadat Shiri, Mohammad hossain Hemmati, Mahvan Mohammadi, Masoud |
author_sort | Salari, Nader |
collection | PubMed |
description | BACKGROUND: Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalence of different primary CNS tumors. METHOD: The study was conducted as a systematic review and meta-analysis by searching international databases, including PubMed, Scopus, Science Direct, Web of science, and the Google Scholar search engine until August 2020. After transferring the studies to information management software (EndNote) and eliminating duplicate studies, the remaining studies were reviewed based on inclusion and exclusion criteria according to three stages of primary and secondary evaluation and qualitative evaluation. Comprehensive Meta-Analysis software, Begg, Mazumdar, and I(2) tests were used for data analysis, publication bias analysis, and heterogeneity analysis, respectively. RESULTS: After performing the systematic review steps, 80 studies were included for final analysis. Based on 8 studies, the prevalence of brain tumors was 70.9%. Also, studies on 7 other studies showed that the prevalence of spinal tumors was 12.2%. A review of 14 studies showed that the prevalence of neuroepithelial tumors was 34.7%. The analysis of 27 studies reported a prevalence of glioma tumors of 42.8%. Analyses performed on other studies showed that the prevalence of pituitary adenomas was 12.2%, embryonal tumors 3.1%, ependymal tumors 3.2%, meningiomas 24.1%, glial tumors 0.8%, astrocytic 20.3%, oligodendroglial 3.9%, glioblastoma 17.7%, schwannoma 6.7%, medulloblastoma 7.7% and Polycystic astrocytomas 3.8%. CONCLUSION: As a result, it can be stated that brain tumors are the most common type of primary CNS tumors. It was also observed that tumors involving neuroepithelial cells are more common in patients than other types of tumors. |
format | Online Article Text |
id | pubmed-9854075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98540752023-01-21 The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis Salari, Nader Ghasemi, Hooman Fatahian, Reza Mansouri, Kamran Dokaneheifard, Sadat Shiri, Mohammad hossain Hemmati, Mahvan Mohammadi, Masoud Eur J Med Res Research BACKGROUND: Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalence of different primary CNS tumors. METHOD: The study was conducted as a systematic review and meta-analysis by searching international databases, including PubMed, Scopus, Science Direct, Web of science, and the Google Scholar search engine until August 2020. After transferring the studies to information management software (EndNote) and eliminating duplicate studies, the remaining studies were reviewed based on inclusion and exclusion criteria according to three stages of primary and secondary evaluation and qualitative evaluation. Comprehensive Meta-Analysis software, Begg, Mazumdar, and I(2) tests were used for data analysis, publication bias analysis, and heterogeneity analysis, respectively. RESULTS: After performing the systematic review steps, 80 studies were included for final analysis. Based on 8 studies, the prevalence of brain tumors was 70.9%. Also, studies on 7 other studies showed that the prevalence of spinal tumors was 12.2%. A review of 14 studies showed that the prevalence of neuroepithelial tumors was 34.7%. The analysis of 27 studies reported a prevalence of glioma tumors of 42.8%. Analyses performed on other studies showed that the prevalence of pituitary adenomas was 12.2%, embryonal tumors 3.1%, ependymal tumors 3.2%, meningiomas 24.1%, glial tumors 0.8%, astrocytic 20.3%, oligodendroglial 3.9%, glioblastoma 17.7%, schwannoma 6.7%, medulloblastoma 7.7% and Polycystic astrocytomas 3.8%. CONCLUSION: As a result, it can be stated that brain tumors are the most common type of primary CNS tumors. It was also observed that tumors involving neuroepithelial cells are more common in patients than other types of tumors. BioMed Central 2023-01-20 /pmc/articles/PMC9854075/ /pubmed/36670466 http://dx.doi.org/10.1186/s40001-023-01011-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Salari, Nader Ghasemi, Hooman Fatahian, Reza Mansouri, Kamran Dokaneheifard, Sadat Shiri, Mohammad hossain Hemmati, Mahvan Mohammadi, Masoud The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
title | The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
title_full | The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
title_fullStr | The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
title_full_unstemmed | The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
title_short | The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
title_sort | global prevalence of primary central nervous system tumors: a systematic review and meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854075/ https://www.ncbi.nlm.nih.gov/pubmed/36670466 http://dx.doi.org/10.1186/s40001-023-01011-y |
work_keys_str_mv | AT salarinader theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT ghasemihooman theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT fatahianreza theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT mansourikamran theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT dokaneheifardsadat theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT shirimohammadhossain theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT hemmatimahvan theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT mohammadimasoud theglobalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT salarinader globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT ghasemihooman globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT fatahianreza globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT mansourikamran globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT dokaneheifardsadat globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT shirimohammadhossain globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT hemmatimahvan globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis AT mohammadimasoud globalprevalenceofprimarycentralnervoussystemtumorsasystematicreviewandmetaanalysis |